Drupal.behaviors.print = function(context) {window.print();window.close();}>
Cancer Genetics Lowers Expected Proceeds from IPO, Increases 2012 Revenues
March 04, 2013
Cancer Genetics Lowers Expected Proceeds from IPO, Increases 2012 Revenues
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Cancer Genetics Plans $48.6M IPO
May 14, 2012 / GenomeWeb Daily News
SQI Diagnostics Files for US IPO
July 7, 2011 / GenomeWeb Daily News
Agendia Files for IPO in Europe
June 6, 2011 / GenomeWeb Daily News
NanoString Technologies Files to Go Public
May 20, 2013 / GenomeWeb Daily News
Cancer Genetics Kidney Cancer Test Approved by CLIA, New York
May 2, 2013 / GenomeWeb Daily News